OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes*

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2007.00839.x
Authors: R. Scott, T. Loeys, M. J. Davies, S. S. Engel, for the Sitagliptin Study 801 Group
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: sitagliptin, metformin, type 2 diabetes, adjunctive therapy, rosiglitazone, HbA1c, glycemic control, body weight, hypoglycemia, gastrointestinal adverse effects, drug safety, thiazolidinediones, inadequate glycemic control, weight gain, tolerability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2158727328
FWCI: 20.52
Cites: 26
Cited by: 229
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms